VHCP Management as of Dec. 31, 2013
Portfolio Holdings for VHCP Management
VHCP Management holds 17 positions in its portfolio as reported in the December 2013 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Gw Pharmaceuticals Plc ads | 15.6 | $29M | 699k | 41.54 | |
| Anacor Pharmaceuticals In | 14.0 | $26M | 1.5M | 16.78 | |
| Ironwood Pharmaceuticals (IRWD) | 11.2 | $21M | 1.8M | 11.61 | |
| Dyax | 10.5 | $20M | 2.6M | 7.54 | |
| BioCryst Pharmaceuticals (BCRX) | 7.2 | $13M | 1.8M | 7.60 | |
| Keryx Biopharmaceuticals | 7.0 | $13M | 1.0M | 12.95 | |
| A.P. Pharma (APPA) | 5.3 | $9.9M | 22M | 0.45 | |
| Ocera Therapeutics | 4.9 | $9.1M | 704k | 12.99 | |
| Vanda Pharmaceuticals (VNDA) | 4.8 | $8.9M | 719k | 12.41 | |
| Chelsea Therapeutics International | 4.1 | $7.6M | 1.7M | 4.44 | |
| Dbv Technologies | 3.9 | $7.2M | 480k | 14.95 | |
| Neurocrine Biosciences (NBIX) | 3.5 | $6.5M | 695k | 9.34 | |
| Therapeuticsmd | 2.4 | $4.4M | 847k | 5.21 | |
| Tesaro | 2.1 | $3.9M | 138k | 28.24 | |
| Biodel | 1.5 | $2.7M | 1.2M | 2.28 | |
| Hyperion Therapeutics | 1.2 | $2.2M | 109k | 20.22 | |
| Alexza Pharmaceuticals | 0.9 | $1.8M | 375k | 4.73 |
